Evidence map›Paper›PMID 41247743›Full record

ArticleHuman vaccines & immunotherapeutics2025

Knowledge of the human papilloma virus and acceptance of its vaccine among male and female young adults in Jeddah, Saudi Arabia: A cross-sectional study.

Reema Alghamdi, Maha Alghamdi, Nada Farsi, Mohammad Alyafi, Shahad Alaidaroos, Nada Almuwalad, Raneem Alsaeedi, Kienaz Alshobaki, Rama Aljabri, Reem Aljadani and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Reema AlghamdiFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Maha AlghamdiFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Nada FarsiDepartment of Dental Public Health, Faculty of Dentistry, King Abdulaziz University, Jeddah, Saudi Arabia.
Mohammad AlyafiDepartment of Obstetrics and Gynecology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Shahad AlaidaroosFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Nada AlmuwaladFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Raneem AlsaeediFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Kienaz AlshobakiFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Rama AljabriFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Reem AljadaniFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Razan BajafarFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Joud AljuhaniFaculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
Nisma MerdadPsychology Department, Effat University, Jeddah, Saudi Arabia.
Roah MerdadDepartment of Community Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-7257-0040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study assessed university students' awareness and knowledge of human papillomavirus (HPV) and its vaccine and willingness to accept vaccination in Jeddah, Saudi Arabia, and identified factors associated with these outcomes. This cross-sectional study was conducted in Jeddah, Saudi Arabia. The study population included university-level male and female students. During the first term of the 2023-2024 academic year, eligible participants were sent an online questionnaire. The study variables included measures of sociodemographic factors, awareness and knowledge of HPV and its vaccine, and vaccine acceptance. We conducted descriptive analysis of awareness, good knowledge, and willingness to accept vaccination, and multivariable logistic regression analyses to determine predictors of these outcomes. The study included 400 participants with a mean age of 21.4years, predominantly female and of Saudi nationality (93%). Awareness of HPV infection was reported by 49.3% of participants, while 44% were aware of the HPV vaccine. Among those aware of HPV, 82.2% recognized its link to cervical cancer, but misconceptions about HPV exist. Only 3.8% of participants had been vaccinated for HPV, and 33.5% expressed willingness to accept the vaccine. Age (per 1year increment; OR: 1.42, 95% CI: 1.25 to 1.62,

Indexed as

Health Knowledge, Attitudes, PracticePapillomavirus InfectionsPapillomavirus VaccinesPatient Acceptance of Health CareVaccinationAdolescentAdultCOVID-19Cross-Sectional StudiesFemaleHuman Papillomavirus VirusesHumansMalePapillomaviridaeSaudi ArabiaStudentsPapillomavirus VaccinesHPV vaccineHPV vaccine acceptancehuman papillomavirus (HPV)

Identifiers

PMID41247743
PMCPMC12629332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.